Tang Wen-Jie, Kong Qing-Cong, Cheng Zi-Xuan, Liang Yun-Shi, Jin Zhe, Chen Lei-Xin, Hu Wen-Ke, Liang Ying-Ying, Wei Xin-Hua, Guo Yuan, Jiang Xin-Qing
Department of Radiology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, Guangdong, China.
Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, Guangdong, China.
Eur Radiol. 2022 Feb;32(2):864-875. doi: 10.1007/s00330-021-08173-5. Epub 2021 Aug 24.
To systematically investigate the effect of imaging features at different DCE-MRI phases to optimise a radiomics model based on DCE-MRI for the prediction of tumour-infiltrating lymphocyte (TIL) levels in breast cancer.
This study retrospectively collected 133 patients with pathologically proven breast cancer, including 73 patients with low TIL levels and 60 patients with high TIL levels. The volumes of breast cancer lesions were manually delineated on T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and each phase of DCE-MRI, followed by 6250 quantitative feature extractions. The least absolute shrinkage and selection operator (LASSO) method was used to select predictive feature sets for the classifiers. Four models were developed for predicting TILs: (1) single enhanced phase radiomics models; (2) fusion enhanced multi-phase radiomics models; (3) fusion multi-sequence radiomics models; and (4) a combined radiomics-based clinical model.
Image features extracted from the delayed phase MRI, especially DCE_Phase 6 (DCE_P6), demonstrated dominant predictive performances over features from other phases. The fusion multi-sequence radiomics model and combined radiomics-based clinical model achieved the highest predictive performances with areas under the curve (AUCs) of 0.934 and 0.950, respectively; however, the differences were not statistically significant.
The DCE-MRI radiomics model, especially image features extracted from the delayed phases, can help improve the performance in predicting TILs. The radiomics nomogram is effective in predicting TILs in breast cancer.
• Radiomics features extracted from DCE-MRI, especially delayed phase images, help predict TIL levels in breast cancer. • We developed a nomogram based on MRI to predict TILs in breast cancer that achieved the highest AUC of 0.950.
系统研究不同DCE-MRI阶段的影像特征对基于DCE-MRI的放射组学模型进行优化以预测乳腺癌中肿瘤浸润淋巴细胞(TIL)水平的影响。
本研究回顾性收集了133例经病理证实的乳腺癌患者,其中73例TIL水平低,60例TIL水平高。在T2加权成像(T2WI)、扩散加权成像(DWI)及DCE-MRI的各阶段手动勾勒乳腺癌病灶体积,随后进行6250次定量特征提取。采用最小绝对收缩和选择算子(LASSO)方法为分类器选择预测特征集。开发了4种预测TIL的模型:(1)单增强期放射组学模型;(2)融合增强多期放射组学模型;(3)融合多序列放射组学模型;(4)基于放射组学的联合临床模型。
从延迟期MRI提取的图像特征,尤其是DCE第6期(DCE_P6),相较于其他阶段的特征表现出显著的预测性能。融合多序列放射组学模型和基于放射组学的联合临床模型预测性能最高,曲线下面积(AUC)分别为0.934和0.950;然而,差异无统计学意义。
DCE-MRI放射组学模型,尤其是从延迟期提取的图像特征,有助于提高预测TIL的性能。放射组学列线图对预测乳腺癌中的TIL有效。
• 从DCE-MRI提取的放射组学特征,尤其是延迟期图像,有助于预测乳腺癌中的TIL水平。• 我们开发了一种基于MRI的列线图来预测乳腺癌中的TIL,其AUC最高达0.950。